As it was found that the LN patient sera treatments induced a milder phenotype the expression of latent TGF-β1 was only assessed at 24 h where it was shown to be significantly increased in response to treatment with sera from patients with active disease (renal BILAG A/B). Here, TGFB1 is linked to lobular neoplasia.